US - POINT Biopharma To Be Acquired By Eli Lilly. - Conventus Law

October 6, 2023 by Rohin Pujari

Skadden is advising POINT Biopharma on its $1.4 billion acquisition by Eli Lilly.

Register for your monthly Asia legal updates from Conventus Law

Error: Contact form not found.